A Study to See How Well Lebrikizumab Works in Adults and Adolescents With Moderate Atopic Dermatitis (Eczema) and High Itch Burden

NCT ID: NCT07006792

This clinical trial is investigating how well a medication called lebrikizumab works for adults and teenagers with moderate atopic dermatitis, commonly known as eczema, who experience a lot of itch...

Recruiting

Phase: PHASE4 Type: interventional Locations: New York, New York, United States, Bay City, Michigan, United States +78 more

Real-world Experience Using Nemolizumab in the Treatment of Moderate-to-Severe Atopic Dermatitis in Adolescents & Adults

NCT ID: NCT06988605

This clinical trial is studying the effectiveness of a medication called nemolizumab (brand name: Nemluvio®) for treating moderate-to-severe atopic dermatitis, a chronic skin condition that causes ...

Recruiting

Type: observational Locations: Buxtehude, , Germany, Castle Rock, Colorado, United States +108 more

A Study to Assess the Efficacy and Safety of Ruxolitinib Cream in Children and Adolescents (6 to <18 Years Old) With Moderate Atopic Dermatitis

NCT ID: NCT06832618

This clinical trial is looking at a new cream called ruxolitinib to see if it is effective and safe for children and teenagers aged 6 to under 18 who have moderate atopic dermatitis, which is a typ...

Recruiting

Phase: PHASE3 Type: interventional Locations: Milwaukee, Wisconsin, United States, Rochester, New York, United States +99 more

Platform Study to Evaluate the Efficacy and Safety of Investigational Compound(s) in Patients With Moderate to Severe Atopic Dermatitis

NCT ID: NCT06947993

This clinical trial is looking at new treatments for people with moderate to severe atopic dermatitis, which is a chronic skin condition that causes itchy and inflamed skin. The trial aims to test ...

Recruiting

Phase: PHASE2 Type: interventional Locations: Troy, Michigan, United States, Houston, Texas, United States +15 more

A Study to Evaluate Adverse Events and Change in Disease State of Oral Upadacitinib in Adolescent Participants Ages 12 to <18 Years Old Diagnosed With Atopic Dermatitis (AD)

NCT ID: NCT05029895

This clinical trial is looking at the safety and effectiveness of a medication called upadacitinib for treating atopic dermatitis (AD), a skin condition that causes inflammation and itching. The st...

Recruiting

Type: observational Locations: Ichinomiya Shi, Aichi, Japan, Nagoya Shi, Aichi, Japan +74 more

An Active Comparator Safety Study Evaluating the Combination of APG777 + APG990 in Moderate-to-Severe Atopic Dermatitis

NCT ID: NCT07027527

This clinical trial is studying the safety and how the body processes a new combination of medicines called APG777 and APG990 for adults with moderate-to-severe atopic dermatitis, a common skin con...

Recruiting

Phase: PHASE1 Type: interventional Locations: Westmead, New South Wales, Australia, Fremantle, Western Australia, Australia +11 more

A Study to Assess Change in Disease Activity in Adolescents and Adults With Moderate to Severe Prurigo-type Atopic Dermatitis in Japan Who Are Treated With Oral Upadacitinib

NCT ID: NCT05451316

This clinical trial is studying the effectiveness of a medication called upadacitinib (UPA) for treating moderate to severe atopic dermatitis (AD) with a specific focus on a type called prurigo-typ...

Recruiting

Type: observational Locations: Sendai Shi, Miyagi, Japan

BROadband vs Narrowband photoTherapy for Eczema Trial Nested in the CACTI Cohort

NCT ID: NCT04818138

The BROadband vs Narrowband photoTherapy for Eczema Trial is a study designed to compare two types of light therapy—Broadband and Narrowband ultraviolet B phototherapy—to see which one works better...

Recruiting

Phase: NA Type: interventional Locations: Toronto, Ontario, Canada

A Study to Assess Adverse Events and Change in Disease Activity Comparing Oral Upadacitinib to Subcutaneous Dupilumab in Children From 2 to Less Than 12 Years of Age With Moderate to Severe Atopic Dermatitis

NCT ID: NCT06461897

This clinical trial is studying two treatments for children aged 2 to less than 12 years who have moderate to severe atopic dermatitis (AD), a skin condition that causes rashes and itching. The tri...

Recruiting

Phase: PHASE3 Type: interventional Locations: Savannah, Georgia, United States, Boise, Idaho, United States +143 more

A Study of Upadacitinib in Adult Participants With Moderate-to-Severe Atopic Dermatitis and Inadequate Response to Dupilumab

NCT ID: NCT06389136

This clinical trial is studying a medication called upadacitinib for adults with moderate to severe atopic dermatitis (AD), a skin condition that causes rashes and itching. The trial aims to find o...

Recruiting

Phase: PHASE3 Type: interventional Locations: Doral, Florida, United States, Dawsonville, Georgia, United States +100 more

A Long-term Safety and Efficacy Study Evaluating APG777 in Atopic Dermatitis

NCT ID: NCT07003425

This clinical trial is studying a medication called APG777 to see how safe and effective it is for people with moderate-to-severe atopic dermatitis (AD), a condition that causes itchy and inflamed ...

Recruiting

Phase: PHASE2 Type: interventional Locations: Coral Gables, Florida, United States, Fountain Valley, California, United States +32 more

A Study Evaluating APG777 in Atopic Dermatitis

NCT ID: NCT06395948

This clinical trial is looking at a new treatment called APG777 for people with moderate-to-severe Atopic Dermatitis (AD), which is a skin condition that causes itchy and inflamed skin. The study i...

Recruiting

Phase: PHASE2 Type: interventional Locations: Coral Gables, Florida, United States, Coral Gables, Florida, United States +91 more

Natural History and Genetics of Food Allergy and Related Conditions

NCT ID: NCT02504853

This clinical trial is studying food allergies and related conditions, such as Loeys-Dietz Syndrome, Atopic Dermatitis, and Eosinophilic Esophagitis. Researchers aim to understand more about what c...

Recruiting

Type: observational Locations: Bethesda, Maryland, United States, Bethesda, Maryland, United States

ATI-045 Versus Placebo in Patients With Moderate-to-Severe Atopic Dermatitis

NCT ID: NCT07011706

This clinical trial is studying a new medication called ATI-045 to see how well it works compared to a placebo (a non-active treatment) for people with moderate-to-severe atopic dermatitis, which i...

Recruiting

Phase: PHASE2 Type: interventional Locations: Bryant, Arkansas, United States, Encinitas, California, United States +20 more

Studies of Skin Microbes in Healthy People and in People With Skin Conditions

NCT ID: NCT00605878

This clinical trial is investigating the tiny living organisms, like bacteria and fungi, that naturally exist on our skin and how they might affect our health, especially in people with skin condit...

Recruiting

Type: observational Locations: Bethesda, Maryland, United States

A Clinical Trial Evaluating a Probiotic Emollient for the Treatment of Pediatric Atopic Dermatitis

NCT ID: NCT07072273

This clinical trial is studying a new skin treatment that contains a helpful type of probiotic called Lactobacillus reuteri BGR46 to see if it can improve symptoms of atopic dermatitis (also known ...

Not yet recruiting

Phase: NA Type: interventional

A Study to Evaluate Microneedle-based Collection of Dermal Interstitial Skin Fluid in Healthy Participants and Atopic Dermatitis Participants

NCT ID: NCT06934980

This clinical trial is designed to explore a new method of collecting a small amount of fluid from the skin using tiny microneedles. The study will involve two groups of participants: healthy indiv...

Recruiting

Type: observational Locations: Montreal, Quebec, Canada

Real World Efficiency of Abrocitinib Treatment at Patients With Moderate to Severe Atopic Dermatitis Who Had Inadequate Response to Previous Biologic Therapies.

NCT ID: NCT06899204

This clinical trial is studying the use of a medication called abrocitinib for patients with moderate to severe atopic dermatitis, a skin condition that causes itchy and inflamed skin. The trial ai...

Not yet recruiting

Type: observational

A Long-term Study of the Medicine Called Abrocitinib in Children Aged 2 Years and Older With Moderate to Severe Eczema

NCT ID: NCT06807281

This clinical trial is studying a medicine called abrocitinib, which is a liquid treatment for children aged 2 years and older who have moderate to severe eczema, also known as atopic dermatitis. T...

Not yet recruiting

Phase: PHASE3 Type: interventional Locations: Indianapolis, Indiana, United States, Greenville, South Carolina, United States

Effect of S. Aureus Skin Decolonization on Disease Severity in Atopic Dermatitis Patients

NCT ID: NCT06397781

This clinical trial is studying whether a treatment that reduces Staphylococcus aureus (S. aureus), a type of bacteria often found on the skin, can help lessen the severity of atopic dermatitis, a ...

Not yet recruiting

Phase: PHASE4 Type: interventional Locations: Boston, Massachusetts, United States

Main Menu

Clinical Trials for Atopic Dermatitis

185 Active Trials Found

A Study to See How Well Lebrikizumab Works in Adults and Adolescents With Moderate Atopic Dermatitis (Eczema) and High Itch Burden

Real-world Experience Using Nemolizumab in the Treatment of Moderate-to-Severe Atopic Dermatitis in Adolescents & Adults

A Study to Assess the Efficacy and Safety of Ruxolitinib Cream in Children and Adolescents (6 to <18 Years Old) With Moderate Atopic Dermatitis

Platform Study to Evaluate the Efficacy and Safety of Investigational Compound(s) in Patients With Moderate to Severe Atopic Dermatitis

A Study to Evaluate Adverse Events and Change in Disease State of Oral Upadacitinib in Adolescent Participants Ages 12 to <18 Years Old Diagnosed With Atopic Dermatitis (AD)

An Active Comparator Safety Study Evaluating the Combination of APG777 + APG990 in Moderate-to-Severe Atopic Dermatitis

A Study to Assess Change in Disease Activity in Adolescents and Adults With Moderate to Severe Prurigo-type Atopic Dermatitis in Japan Who Are Treated With Oral Upadacitinib

BROadband vs Narrowband photoTherapy for Eczema Trial Nested in the CACTI Cohort

A Study to Assess Adverse Events and Change in Disease Activity Comparing Oral Upadacitinib to Subcutaneous Dupilumab in Children From 2 to Less Than 12 Years of Age With Moderate to Severe Atopic Dermatitis

A Study of Upadacitinib in Adult Participants With Moderate-to-Severe Atopic Dermatitis and Inadequate Response to Dupilumab

A Long-term Safety and Efficacy Study Evaluating APG777 in Atopic Dermatitis

A Study Evaluating APG777 in Atopic Dermatitis

Natural History and Genetics of Food Allergy and Related Conditions

ATI-045 Versus Placebo in Patients With Moderate-to-Severe Atopic Dermatitis

Studies of Skin Microbes in Healthy People and in People With Skin Conditions

A Clinical Trial Evaluating a Probiotic Emollient for the Treatment of Pediatric Atopic Dermatitis

A Study to Evaluate Microneedle-based Collection of Dermal Interstitial Skin Fluid in Healthy Participants and Atopic Dermatitis Participants

Real World Efficiency of Abrocitinib Treatment at Patients With Moderate to Severe Atopic Dermatitis Who Had Inadequate Response to Previous Biologic Therapies.

A Long-term Study of the Medicine Called Abrocitinib in Children Aged 2 Years and Older With Moderate to Severe Eczema

Effect of S. Aureus Skin Decolonization on Disease Severity in Atopic Dermatitis Patients

Related Conditions